IRWDStock Financials & Fundamentals
Company Info
Company Full Name
Ironwood Pharmaceuticals Inc
Full name of the company.
Industry Name
Drug Manufacturers - Specialty & Generic
Industry name
Major Industry Name
Biotechnology
Major industry name
Sector Name
Healthcare
Sector name
Market Info
Current Price
$4.31
Current price of the stock
Trading Volume
$2M
Trading volume of the stock
Market Capitalization
$674.2M
Market capitalization of the company
Market Cap Category
Small Cap
Category of market capitalization
Long-Term Growth Estimate
21.76%
Long-term growth mean estimate
Analyst Rating Mean
3.00
Mean analyst rating
Potential Upside
41.20%
Potential price appreciation based on analyst price targets
EPS Surprise Percentage Difference
-
Percentage difference of EPS surprise
Dividends
Dividend Change (1 Year)
-
Dividend change over 1 year
Dividend Rate
$0.00
Shows the amount of dividend paid
Balance Sheet
Total Debt to Equity Ratio
-2.38
Total debt to total equity ratio
Current Ratio
6.06
Current ratio
Company Profitability
Gross Profit Margin
77.22%
Gross profit margin
Operating Profit Margin
70.16%
Operating profit margin
EBIT Margin
70.16%
Earnings before interest and taxes (EBIT) margin
EBITDA Margin
61.16%
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
Pretax Profit Margin
65.22%
Pretax profit margin
Net Profit Margin
33.36%
Net profit margin
Return on Equity (ROE)
-5.75%
Measures profitability relative to shareholders' equity
Return on Tangible Equity
-31.38%
ROE excluding intangible assets
Return on Assets (ROA)
47.02%
Measures profitability relative to total assets
Return on Invested Capital (ROIC)
22.98%
Measures profitability relative to invested capital
Management Effectiveness
Asset Turnover (quarterly)
0.40
Asset turnover ratio
Inventory Turnover (quarterly)
-
Inventory turnover ratio
Receivables Turnover (quarterly)
1.00
Receivables turnover ratio
Days Sales Outstanding
89.75
Average number of days it takes to collect receivables
Valuation Measures
Price-to-Earnings (P/E) Ratio
5.51
Measures valuation relative to earnings
Forward P/E Ratio
12.33
P/E based on future earnings estimates
Price-to-Sales (P/S) Ratio
1.73
Measures valuation relative to sales
Price-to-Book (P/B) Ratio
2.59
Measures valuation relative to book value
Price-to-Operating Cash Flow (P/OCF) Ratio
2.91
Measures valuation relative to operating cash flow
Price-to-Free Cash Flow (P/FCF) Ratio
2.91
Measures valuation relative to free cash flow
Cash Flow Statement
Net Acquisitions/Divestitures
0
Indicates company's M&A activity
IRWDStock Financials & Fundamentals
Company Info
| Parameter | Value | Description |
|---|---|---|
| Company Full Name | Ironwood Pharmaceuticals Inc | Full name of the company. |
| Industry Name | Drug Manufacturers - Specialty & Generic | Industry name |
| Major Industry Name | Biotechnology | Major industry name |
| Sector Name | Healthcare | Sector name |
Market Info
| Parameter | Value | Description |
|---|---|---|
| Current Price | $4.31 | Current price of the stock |
| Trading Volume | $2M | Trading volume of the stock |
| Market Capitalization | $674.2M | Market capitalization of the company |
| Market Cap Category | Small Cap | Category of market capitalization |
| Long-Term Growth Estimate | 21.76% | Long-term growth mean estimate |
| Analyst Rating Mean | 3.00 | Mean analyst rating |
| Potential Upside | 41.20% | Potential price appreciation based on analyst price targets |
| EPS Surprise Percentage Difference | - | Percentage difference of EPS surprise |
Dividends
| Parameter | Value | Description |
|---|---|---|
| Dividend Change (1 Year) | - | Dividend change over 1 year |
| Dividend Rate | $0.00 | Shows the amount of dividend paid |
Balance Sheet
| Parameter | Value | Description |
|---|---|---|
| Total Debt to Equity Ratio | -2.38 | Total debt to total equity ratio |
| Current Ratio | 6.06 | Current ratio |
Company Profitability
| Parameter | Value | Description |
|---|---|---|
| Gross Profit Margin | 77.22% | Gross profit margin |
| Operating Profit Margin | 70.16% | Operating profit margin |
| EBIT Margin | 70.16% | Earnings before interest and taxes (EBIT) margin |
| EBITDA Margin | 61.16% | Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin |
| Pretax Profit Margin | 65.22% | Pretax profit margin |
| Net Profit Margin | 33.36% | Net profit margin |
| Return on Equity (ROE) | -5.75% | Measures profitability relative to shareholders' equity |
| Return on Tangible Equity | -31.38% | ROE excluding intangible assets |
| Return on Assets (ROA) | 47.02% | Measures profitability relative to total assets |
| Return on Invested Capital (ROIC) | 22.98% | Measures profitability relative to invested capital |
Management Effectiveness
| Parameter | Value | Description |
|---|---|---|
| Asset Turnover (quarterly) | 0.40 | Asset turnover ratio |
| Inventory Turnover (quarterly) | - | Inventory turnover ratio |
| Receivables Turnover (quarterly) | 1.00 | Receivables turnover ratio |
| Days Sales Outstanding | 89.75 | Average number of days it takes to collect receivables |
Valuation Measures
| Parameter | Value | Description |
|---|---|---|
| Price-to-Earnings (P/E) Ratio | 5.51 | Measures valuation relative to earnings |
| Forward P/E Ratio | 12.33 | P/E based on future earnings estimates |
| Price-to-Sales (P/S) Ratio | 1.73 | Measures valuation relative to sales |
| Price-to-Book (P/B) Ratio | 2.59 | Measures valuation relative to book value |
| Price-to-Operating Cash Flow (P/OCF) Ratio | 2.91 | Measures valuation relative to operating cash flow |
| Price-to-Free Cash Flow (P/FCF) Ratio | 2.91 | Measures valuation relative to free cash flow |
Cash Flow Statement
| Parameter | Value | Description |
|---|---|---|
| Net Acquisitions/Divestitures | 0 | Indicates company's M&A activity |